Lifting the innate immune barriers to antitumor immunity
The immune system evolved for adequate surveillance and killing of pathogens while minimizing host damage, such as due to chronic or exaggerated inflammation and autoimmunity. This is achieved by negative regulators and checkpoints that limit the magnitude and time course of the immune response. Tum...
Saved in:
| Main Authors: | Carla V Rothlin, Sourav Ghosh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000695.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A targeted MAVS fusion protein for controlled innate immune activation and antitumor therapy
by: Muhan Wang, et al.
Published: (2025-12-01) -
Salmonella LVR01 triggers antagonistic two-armed innate immune memory that impacts on antitumor efficacy
by: Sofía Chilibroste, et al.
Published: (2025-04-01) -
The Epitranscriptome and Innate Immunity.
by: Mary A O'Connell, et al.
Published: (2015-12-01) -
CLN-619, a MICA/B monoclonal antibody that promotes innate immune cell-mediated antitumor activity
by: Naveen K Mehta, et al.
Published: (2025-04-01) -
Innate-Adaptive Immune Crosstalk
by: Anil Shanker, et al.
Published: (2015-01-01)